50% off Premium Yearly

NYSE:ELAN
This summary was created by AI, based on 1 opinions in the last 12 months.
Elanco Animal Health has garnered positive reviews from experts, particularly highlighting their impressive turnaround in recent times. Analysts note that the company's strategic initiatives and operational improvements have positively impacted their financial performance, instilling confidence in their future growth prospects. The restructuring efforts are seen as a key factor driving optimism, as Elanco positions itself better within the competitive landscape of animal health products. Overall, the feedback from various experts underscores a renewed sense of optimism around the company's ability to capitalize on market opportunities and enhance shareholder value.
Spun off from Eli Lilly in 2018. Reported a mixed report today, including their pet business missing as guidance for the current quarter fell short. They will sell its Aqua business to Merck Animal Health, announced restructuring/job cuts and will increase cash flow conversions four times this year, which is a priority. This gives him some hope in the name.
Elanco Animal Health is a American stock, trading under the symbol ELAN (previously ELAN-N on Stockchase) on the New York Stock Exchange (ELAN). It is usually referred to as NYSE:ELAN or ELAN
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on ELAN (previously ELAN-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is WEAK BUY. Read the latest stock experts' ratings for Elanco Animal Health.
Elanco Animal Health was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Elanco Animal Health.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Elanco Animal Health.
Elanco Animal Health is covered by Stockchase experts and is worth watching.
On 2026-06-22, Elanco Animal Health (ELAN) stock closed at a price of $23.91.
Is impressed with their turnaround.